All data are based on the daily closing price as of March 16, 2026
a

ASKA Pharmaceutical Holdings

4886.TSE
13.85 USD
-0.08
-0.57%

Overview

Last close
13.85 usd
Market cap
393.34M usd
52 week high
17.48 usd
52 week low
11.96 usd
Target price
15.69 usd

Valuation

P/E
12.1536
Forward P/E
N/A
Price/Sales
0.9122
Price/Book Value
0.9171
Enterprise Value
440.42M usd
EV/Revenue
1.047
EV/EBITDA
8.3868

Key financials

Revenue TTM
420.64M usd
Gross Profit TTM
203.44M usd
EBITDA TTM
45.52M usd
Earnings per Share
1.06 usd
Dividend
0.19 usd
Total assets
719.62M usd
Net debt
51.26M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. The company was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top